ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE

被引:180
作者
HENDELES, L
WEINBERGER, M
BIGHLEY, L
机构
[1] UNIV IOWA,COLL PHARM,PEDIAT ALLERGY CLIN,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DIV PEDIAT ALLERGY & PULMONARY,IOWA CITY,IA 52242
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1977年 / 34卷 / 05期
关键词
D O I
10.1093/ajhp/34.5.525
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:525 / 527
页数:3
相关论文
共 15 条
[1]  
COATES PE, 1975, NOV ANN M AC PHARM S
[2]  
DIAMOND L, 1970, ARCH INT PHARMACOD T, V185, P246
[3]  
ELLIS EF, 1976, PEDIATRICS, V58, P542
[4]   PHARMACOKINETICS IN CLINICAL PRACTICE .2. APPLICATIONS [J].
GIBALDI, M ;
LEVY, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18) :1987-1992
[5]   EVALUATION OF DIGOXIN BIOAVAILABILITY IN SINGLE-DOSE STUDIES [J].
GREENBLATT, DJ ;
DUHME, DW ;
KOCHWESE.J ;
SMITH, TW .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (13) :651-654
[6]  
HARTNETT JS, 1974, MED J AUST, V61, P532
[7]  
JORGENSEN M, 1961, ACTA PHARMACOL TOX, V18, P129
[8]   EFFECT OF ETHANOL ON THEOPHYLLINE ABSORPTION IN HUMANS [J].
KOYSOOKO, R ;
ELLIS, EF ;
LEVY, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (02) :299-301
[9]  
MITENKO PA, 1973, CLIN PHARMACOL THER, V14, P509
[10]  
MITENKO PA, 1974, CLIN PHARMACOL THER, V16, P720